Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.

Documenti analoghi

• Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
  di: Bayer, A S, et al.
  Pubblicazione: (1988)
• Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
  di: Kureishi, A, et al.
  Pubblicazione: (1994)
• Characterization of impermeability variants of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis.
  di: Bayer, A S, et al.
  Pubblicazione: (1987)
• Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
  di: Bayer, A S, et al.
  Pubblicazione: (1987)
• Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
  di: Bedard, J, et al.
  Pubblicazione: (1989)